Novel therapies for advanced skin carcinomas

Advanced skin carcinomas are a serious therapeutic problem. The statistical analysis shows a continuous increase in the incidence of both melanoma and non-melanoma skin cancers. Traditional therapies are characterized by low effectiveness and patients overall survival is not affected by them. By und...

Descripción completa

Detalles Bibliográficos
Autores principales: Modrakowska, Paulina, Balik, Karolina, Maj, Małgorzata, Bajek, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675086/
https://www.ncbi.nlm.nih.gov/pubmed/33240003
http://dx.doi.org/10.5114/ada.2020.100479
_version_ 1783611642053918720
author Modrakowska, Paulina
Balik, Karolina
Maj, Małgorzata
Bajek, Anna
author_facet Modrakowska, Paulina
Balik, Karolina
Maj, Małgorzata
Bajek, Anna
author_sort Modrakowska, Paulina
collection PubMed
description Advanced skin carcinomas are a serious therapeutic problem. The statistical analysis shows a continuous increase in the incidence of both melanoma and non-melanoma skin cancers. Traditional therapies are characterized by low effectiveness and patients overall survival is not affected by them. By understanding the molecular pathways that lead to the neoplastic transformation and thanks to the knowledge of the immune system, it is possible to use personalized medicine in novel therapies for advanced skin carcinomas.
format Online
Article
Text
id pubmed-7675086
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-76750862020-11-24 Novel therapies for advanced skin carcinomas Modrakowska, Paulina Balik, Karolina Maj, Małgorzata Bajek, Anna Postepy Dermatol Alergol Review Paper Advanced skin carcinomas are a serious therapeutic problem. The statistical analysis shows a continuous increase in the incidence of both melanoma and non-melanoma skin cancers. Traditional therapies are characterized by low effectiveness and patients overall survival is not affected by them. By understanding the molecular pathways that lead to the neoplastic transformation and thanks to the knowledge of the immune system, it is possible to use personalized medicine in novel therapies for advanced skin carcinomas. Termedia Publishing House 2020-11-07 2020-10 /pmc/articles/PMC7675086/ /pubmed/33240003 http://dx.doi.org/10.5114/ada.2020.100479 Text en Copyright © 2020 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Review Paper
Modrakowska, Paulina
Balik, Karolina
Maj, Małgorzata
Bajek, Anna
Novel therapies for advanced skin carcinomas
title Novel therapies for advanced skin carcinomas
title_full Novel therapies for advanced skin carcinomas
title_fullStr Novel therapies for advanced skin carcinomas
title_full_unstemmed Novel therapies for advanced skin carcinomas
title_short Novel therapies for advanced skin carcinomas
title_sort novel therapies for advanced skin carcinomas
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675086/
https://www.ncbi.nlm.nih.gov/pubmed/33240003
http://dx.doi.org/10.5114/ada.2020.100479
work_keys_str_mv AT modrakowskapaulina noveltherapiesforadvancedskincarcinomas
AT balikkarolina noveltherapiesforadvancedskincarcinomas
AT majmałgorzata noveltherapiesforadvancedskincarcinomas
AT bajekanna noveltherapiesforadvancedskincarcinomas

Ejemplares similares